Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Dose Escalation Study of AAV2-hCHM in Subjects With CHM (Choroideremia) Gene Mutations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02341807
Recruitment Status : Active, not recruiting
First Posted : January 19, 2015
Last Update Posted : March 12, 2019
Sponsor:
Collaborators:
Children's Hospital of Philadelphia
University of Pennsylvania
Massachusetts Eye and Ear Infirmary
Information provided by (Responsible Party):
Spark Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : October 2019
  Estimated Study Completion Date : October 2019